442 Results
Sort By:
Published on February 13, 2019
Mayo Clinic Laboratories and German diagnostics developer Numares will partner to develop clinical diagnostic tests designed to measure clusters of risk factors rather than individual biomarkers, through a collaboration whose value was not disclosed. The diagnostics to be developed will target specific diseases that include cardiovascular disease, kidney disease and…
Published on January 31, 2019
Microbial genomics company uBiome has awarded researchers at Stanford University a grant to study the role of abnormal semen microbiome in infertility. The goal of the study—led by Professor of Obstetrics and Gynecology, Barry Behr, Ph.D., and Sara Vaughn, M.D., a fellow in reproductive endocrinology and infertility—is to analyze the…
Published on January 7, 2019
A physician may find themselves in a diagnostic odyssey if a patient's symptoms or phenotypes point in the direction of a rare genetic disease. But, an artificial intelligence-based program that indicates the most likely genetic disorder based on facial phenotypes is giving physicians a place to start. The program can…
Published on December 19, 2018
Biocept will apply Prognos’ artificial intelligence (AI) platform toward the use of its clinical laboratory diagnostics for precision oncology, through a collaboration whose value was not disclosed. The companies have signed a software license and laboratory data supply agreement, through which Biocept agreed to supply de-identified data from its liquid…
Published on November 27, 2018
WuXi NextCODE is partnering with Irish life sciences company Genomics Medicine Ireland (GMI) and The Ireland Strategic Investment Fund (ISIF) on a $400 million initiative intended to position Ireland as a key hub for genomics research and development. GMI will become the Irish subsidiary of WuXi NextCODE, with plans to…
Published on October 15, 2018
Microsoft will combine its Azure cloud technology and Cognitive Services application program interfaces (APIs) with the artificial intelligence (AI)-based microbiome data management platform of Eagle Genomics to carry out microbiomic research into immune disorders and antibiotic resistance, Eagle said today. The collaboration—whose value was not disclosed—will be Microsoft’s first partnership…
Published on October 1, 2018
Caris Life Sciences said today it has raised $150 million in growth capital in the form of senior secured debt and convertible notes from TPG Sixth Street Partners (TSSP), saying the funding would in part accelerate development of its Next Generation Profiling offerings. Next Generation Profiling combines the company’s Caris…
Published on September 20, 2018
Predicine and Flagship Biosciences said today they will partner to provide complimentary and comprehensive biomarker profiling for immuno-oncology clinical trials, through a collaboration whose value was not disclosed. The collaboration will combine Predicine’s GeneRADAR molecular insights platform with Flagship’s artificial intelligence-enabled computational tissue analysis (cTA) digital pathology platform, with the…
Published on September 19, 2018
Artificial intelligence has a way of inspiring wonder and uneasiness at the same time, particularly when it shows that it can outperform humans while hiding exactly how it goes about its business. The latest group of humans to be mysteriously surpassed by artificial intelligence, or AI, consists of pathologists—specifically, pathologists…
Published on September 6, 2018
Precision healthcare company GNS Health announced this week it will collaborate with Amgen and the Alliance for Clinical Trials in Oncology (Alliance) to use its causal artificial intelligence (AI) and simulation technology to analyze combined clinical trial data of metastatic colorectal cancer (CRC) to better understand patient response to Amgen’s…
Published on August 30, 2018
As the U.S. marked the 242nd anniversary of its independence, the mother country also had reason to celebrate. England’s National Health Service commemorated its 70th birthday not with a cake or candles, but with a nicely timed announcement that the 70,000th genome had been sequenced of the 100,000 planned by…
Published on August 2, 2018
New technologies and computational methods are introduced virtually every day to improve the use of “omics” in diagnostics and precision medicine. While most of these are either genuine improvements to existing technologies or represent a new method or technique, the vast majority of these introductions only effect incremental change. However,…
Published on July 19, 2018
The U.S. Department of Veterans Affairs (VA) and IBM Watson Health said they have extended their two-year-old precision oncology partnership, designed to help interpret cancer data in the treatment of veterans through artificial intelligence (AI). Launched in June 2016 as part of the National Cancer Moonshot Initiative, the partnership has…
Published on July 16, 2018
Verge Genomics said today it has raised $32 million in Series A financing toward further development of new treatments by combining machine learning and neuroscience with experimental biology. Venture capital firm DFJ led the financing, which also attracted new biotech investors that included WuXi AppTec’s Corporate Venture Fund, as well…
Published on July 3, 2018
Indivumed and the Institute of Molecular and Cell Biology (IMCB) of Singapore’s Agency for Science, Technology and Research (A*STAR) said today they will build what they said was the first global multiomics cancer database. The value of the collaboration was not disclosed. The partners said they have agreed to carry…